Market Overview

Hearing UBS Says Endo Likely to be Sold at $40+/share.

Posted-In: UBSAnalyst Color News Rumors M&A Analyst Ratings Movers

 

Related Articles (ENDP)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional